Skip to main content
U.S. flag
Health and Human Services Logo

An official website of the Department of Health & Human Services

menu-iconMore mobile-close-icon
mobile-back-btn-icon Back
  • menu-iconMenu
  • mobile-search-icon
AHRQ: Agency for Healthcare Research and Quality
  • Search All AHRQ Sites
  • Careers
  • Contact Us
  • Español
  • FAQs
  • Email Updates
MEPS Home Medical Expenditure Panel Survey
Font Size:
Contact MEPS FAQ Site Map  
S
M
L
XL
 
 
Prescribed Drug Estimates: 2003
Table 1.1 Top Prescribed Drugs by Total Expenditures, 2003

Prescribed
drug name

Total expenditures
ranking

Total
expenditures
Total number of
persons with expenditures

Lipitor

1

7,754,809,953

13,073,351

Zocor

2

5,473,759,675

7,463,572

Prevacid

3

3,472,009,782

5,221,943

Nexium

4

3,156,683,387

4,480,954

Celebrex

5

2,861,815,431

6,036,805

Norvasc

6

2,363,518,249

5,930,562

Advair

7

2,217,752,072

4,248,018

Paxil

8

2,212,583,629

4,465,763

Allegra

9

2,183,533,841

9,238,435

Zoloft

10

2,103,096,705

4,675,609

Standard Errors for Table 1.1: Top Prescribed Drugs by Total Expenditures, 2003

Prescribed
drug name
Total
expenditures
Total number of
persons with expenditures

Lipitor

 405,677,623.26

563,839.12
Zocor

404,639,922.03

381,885.59
Prevacid

236,946,198.23

278,809.75
Nexium

275,065,585.67

268,047.95
Celebrex

206,421,132.42

321,224.42
Norvasc

146,594,405.46

303,181.07
Advair

184,718,425.12

258,394.94
Paxil

183,934,863.59

240,780.35
Allegra

156,107,241.62

409,385.93
Zoloft

162,355,269.35

266,086.16

 

 

MEPS HOME . CONTACT MEPS . MEPS FAQ . MEPS SITE MAP . MEPS PRIVACY POLICY . ACCESSIBILITY . VIEWERS & PLAYERS . COPYRIGHT
Back to topGo back to top
Back to Top Go back to top

Connect With Us

Facebook Twitter You Tube LinkedIn

Sign up for Email Updates

To sign up for updates or to access your subscriber preferences, please enter your email address below.

Agency for Healthcare Research and Quality

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364

  • Careers
  • Contact Us
  • Español
  • FAQs
  • Accessibility
  • Disclaimers
  • EEO
  • Electronic Policies
  • FOIA
  • HHS Digital Strategy
  • HHS Nondiscrimination Notice
  • Inspector General
  • Plain Writing Act
  • Privacy Policy
  • Viewers & Players
  • U.S. Department of Health & Human Services
  • The White House
  • USA.gov